目的调查和分析成人型Still病(AOSD)确诊前经验性或试验性用药(EEM)中的安全问题。
方法通过医院信息系统收集吉林大学第二医院2019年1月1日至2023年12月31日收治的AOSD住院患者,筛选出入院时被误诊的患者。对误诊患者的主要临床特征、实验室检查、误诊情况、EEM使用情况及其相关药物不良反应(ADR)和潜在相互作用等进行描述性分析。
结果设定时段内医院共收治49例AOSD患者,其中16例在入院时被误诊为其他疾病(32.7%)。16例误诊患者中,男性10例,女性6例,中位年龄53岁;主要临床表现为发热(15例)、关节痛/关节炎(10例)、淋巴结肿大(10例)、皮疹(9例)、胸腔或心包积液(6例)、肺炎(5例)、脾大(4例)和咽痛(4例)。实验室检查异常包括白细胞计数升高(13例)、血小板计数升高(8例)、血清铁蛋白升高(>500 μg/L,12例)和肝功能异常(9例)。16例误诊患者入院前外院诊治的中位时间为5.5个月,从入院至确诊AOSD的中位时间12 d。在AOSD确诊前均接受了较长时间的EEM治疗,其中使用了抗菌药物、中药制剂、保肝药物、抗过敏药和抗病毒药的患者分别为15、12、11、3和2例。4例发生与EEM相关的ADR,均为抗菌药物所致。4例患者的治疗药物中存在潜在相互作用。
结论AOSD的误诊率较高,患者在明确诊断前往往接受了多种EEM,存在ADR和发生药物相互作用的风险。
ObjectiveTo investigate and analyze the safety of empirical or experimental medication (EEM) for adult-onset Still disease (AOSD) before diagnosis.
MethodsThe AOSD inpatients admitted to the Second Hospital of Jilin University from January 1, 2019 to December 31, 2023 were collected through hospital information system, and those who were misdiagnosed on admission were screened out. The main clinical characteristics, laboratory tests, misdiagnosis situation, the use of EEM and their adverse drug reactions (ADR), and the potential drug-drug interactions in the misdiagnosed patients were analyzed by descriptive statistics.
ResultsDuring the set time period, a total of 49 patients with AOSD were admitted to the hospital, of which 16 (32.7%) were misdiagnosed with other diseases on admission. Among the 16 patients, 10 were male and 6 were female, with a median age of 53 years. The main clinical manifestations were fever (in 15 patients), arthralgia/arthritis (in 10 patients), lymphadenopathy (in 10 patients), rash (in 9 patients), pleural or pericardial effusion (in 6 patients), pneumonia (in 5 patients), splenomegaly (in 4 patients) and sore throat (in 4 patients). Abnormalities in laboratory tests included white blood cell count elevation (in 13 patients), platelets count elevation (in 8 patients), serum ferritin elevation (>500 μg/L, in 12 patients), and abnormal liver function (in 9 patients). The median time of treatment before admission was 5.5 months (11 days to 27.0 months), and the median time from admission to diagnosis of AOSD was 12 days. Before the diagnosis of AOSD, all patients received a long time of EEM, including antibiotics, traditional Chinese medicine preparations, liver-protection drugs, anti-allergic drugs and antiviral drugs in 15, 12, 11, 3 and 2 patients, respectively. Four patients experienced ADRs related to EEM, all of which were caused by antibiotics. There were potential interactions in the therapeutic drugs in 4 patients.
ConclusionThe misdiagnosis rate of AOSD was high. Patients might had accepted multiple EEMs before the definite diagnosis, which posed risks of ADRs and drug interactions.
丛珊,刘一鸣,魏显苹,等. 成人型Still病确诊前经验性或试验性用药安全性问题的调查与分析[J]. 药物不良反应杂志,2025,27(03):176-181.
DOI:10.3760/cma.j.cn114015-20240603-00410版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
丛珊:文章撰写、病例信息收集及提取;刘一鸣、魏显苹、侯继秋、陈俊俊:病例信息收集及提取;王冬雪:研究设计

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。